225 related articles for article (PubMed ID: 24169063)
1. A patient preference and satisfaction study of ciclesonide nasal aerosol and mometasone furoate aqueous nasal spray in patients with perennial allergic rhinitis.
Berger WE; Prenner B; Turner R; Meltzer EO
Allergy Asthma Proc; 2013; 34(6):542-50. PubMed ID: 24169063
[TBL] [Abstract][Full Text] [Related]
2. Nasal deposition of ciclesonide nasal aerosol and mometasone aqueous nasal spray in allergic rhinitis patients.
Emanuel IA; Blaiss MS; Meltzer EO; Evans P; Connor A
Am J Rhinol Allergy; 2014; 28(2):117-21. PubMed ID: 24598007
[TBL] [Abstract][Full Text] [Related]
3. Preference evaluation and perceived sensory comparison of fluticasone furoate and mometasone furoate intranasal sprays in allergic rhinitis.
Yonezaki M; Akiyama K; Karaki M; Goto R; Inamoto R; Samukawa Y; Kobayashi R; Kobayashi E; Hoshikawa H
Auris Nasus Larynx; 2016 Jun; 43(3):292-7. PubMed ID: 26498699
[TBL] [Abstract][Full Text] [Related]
4. A preference evaluation study comparing the sensory attributes of mometasone furoate and fluticasone propionate nasal sprays by patients with allergic rhinitis.
Meltzer EO; Bardelas J; Goldsobel A; Kaiser H
Treat Respir Med; 2005; 4(4):289-96. PubMed ID: 16086602
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and tolerability study of ciclesonide nasal aerosol in patients with perennial allergic rhinitis.
Mohar D; Berger WE; Laforce C; Raphael G; Desai SY; Huang H; Hinkle J
Allergy Asthma Proc; 2012; 33(1):19-26. PubMed ID: 22370530
[TBL] [Abstract][Full Text] [Related]
6. Preferences of adult patients with allergic rhinitis for the sensory attributes of fluticasone furoate versus fluticasone propionate nasal sprays: a randomized, multicenter, double-blind, single-dose, crossover study.
Meltzer EO; Stahlman JE; Leflein J; Meltzer S; Lim J; Dalal AA; Prillaman BA; Philpot EE
Clin Ther; 2008 Feb; 30(2):271-9. PubMed ID: 18343265
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of mometasone furoate nasal spray for nasal symptoms, quality of life, rhinitis-disturbed sleep, and nasal nitric oxide in patients with perennial allergic rhinitis.
Yamada T; Yamamoto H; Kubo S; Sakashita M; Tokunaga T; Susuki D; Narita N; Ogi K; Kanno M; Yamashita S; Terasawa Y; Kayano Y; Masada M; Fujieda S
Allergy Asthma Proc; 2012; 33(2):e9-16. PubMed ID: 22525384
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of ciclesonide and desisobutyryl ciclesonide after administration via aqueous nasal spray or hydrofluoroalkane nasal aerosol compared with orally inhaled ciclesonide: an open-label, single-dose, three-period crossover study in healthy volunteers.
Nave R; Herzog R; Laurent A; Wingertzahn MA
Clin Ther; 2009 Dec; 31(12):2988-99. PubMed ID: 20110036
[TBL] [Abstract][Full Text] [Related]
9. No mucosal atrophy and reduced inflammatory cells: active-controlled trial with yearlong fluticasone furoate nasal spray.
Fokkens WJ; Rinia B; van Drunen CM; Hellings PW; Hens G; Jansen A; Blom H; Wu W; Clements DS; Lee LA; Philpot EE
Am J Rhinol Allergy; 2012; 26(1):36-44. PubMed ID: 22391079
[TBL] [Abstract][Full Text] [Related]
10. A study of the efficacy and safety of ciclesonide hydrofluoroalkane nasal aerosol in patients with seasonal allergic rhinitis from mountain cedar pollen.
Ratner PH; Andrews C; Martin B; Howland W; Desai SY; Huang H; Hinkle J; Bode F
Allergy Asthma Proc; 2012; 33(1):27-35. PubMed ID: 22370531
[TBL] [Abstract][Full Text] [Related]
11. Absence of growth retardation in children with perennial allergic rhinitis after one year of treatment with mometasone furoate aqueous nasal spray.
Schenkel EJ; Skoner DP; Bronsky EA; Miller SD; Pearlman DS; Rooklin A; Rosen JP; Ruff ME; Vandewalker ML; Wanderer A; Damaraju CV; Nolop KB; Mesarina-Wicki B
Pediatrics; 2000 Feb; 105(2):E22. PubMed ID: 10654982
[TBL] [Abstract][Full Text] [Related]
12. An investigation of the pharmacokinetics, pharmacodynamics, safety, and tolerability of ciclesonide hydrofluoroalkane nasal aerosol in healthy subjects and subjects with perennial allergic rhinitis.
Ratner P; Wingertzahn MA; Herzog R; Huang H; Desai SY; Maier G; Nave R
Pulm Pharmacol Ther; 2011 Aug; 24(4):426-33. PubMed ID: 21501692
[TBL] [Abstract][Full Text] [Related]
13. Mometasone furoate nasal spray for moderate-to-severe nasal congestion in subjects with seasonal allergic rhinitis.
Meltzer EO; Shekar T; Teper AA
Allergy Asthma Proc; 2011; 32(2):159-67. PubMed ID: 21439168
[TBL] [Abstract][Full Text] [Related]
14. Symptom suppression in subjects with perennial allergic rhinitis treated with mometasone furoate nasal spray.
Clement P; Gates D
Int Arch Allergy Immunol; 2012; 157(4):387-90. PubMed ID: 22123158
[TBL] [Abstract][Full Text] [Related]
15. A 26-week tolerability study of ciclesonide nasal aerosol in patients with perennial allergic rhinitis.
Berger WE; Mohar DE; LaForce C; Raphael G; Desai SY; Huang H; Hinkle J
Am J Rhinol Allergy; 2012; 26(4):302-7. PubMed ID: 22801019
[TBL] [Abstract][Full Text] [Related]
16. Patient preferences and sensory comparisons of three intranasal corticosteroids for the treatment of allergic rhinitis.
Bachert C; El-Akkad T
Ann Allergy Asthma Immunol; 2002 Sep; 89(3):292-7. PubMed ID: 12269650
[TBL] [Abstract][Full Text] [Related]
17. Comparison of sensory attributes and immediate efficacy of intranasal ciclesonide and fluticasone propionate in allergic rhinitis: a randomized controlled trial.
Varshney J; Varshney H; Dutta SK; Hazra A
Indian J Pharmacol; 2012; 44(5):550-4. PubMed ID: 23112411
[TBL] [Abstract][Full Text] [Related]
18. Comparison of once daily mometasone furoate (Nasonex) and fluticasone propionate aqueous nasal sprays for the treatment of perennial rhinitis. The 194-079 Study Group.
Mandl M; Nolop K; Lutsky BN
Ann Allergy Asthma Immunol; 1997 Sep; 79(3):237-45. PubMed ID: 9305231
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and long-term safety of mometasone furoate nasal spray in children with perennial allergic rhinitis.
Baena-Cagnani CE; Patel P
Curr Med Res Opin; 2010 Sep; 26(9):2047-55. PubMed ID: 20629597
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the efficacy and safety of ciclesonide hydrofluoroalkane nasal aerosol, 80 or 160 μg once daily, for the treatment of seasonal allergic rhinitis.
Ratner P; Jacobs R; Mohar D; Huang H; Desai SY; Hinkle J
Ann Allergy Asthma Immunol; 2010 Dec; 105(6):471-9. PubMed ID: 21130386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
